{"nct_id":"NCT04209465","title":"A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.","status":"TERMINATED","status_verified_date":"2024-04","start_date":"2019-12-19","start_date_type":"ACTUAL","primary_completion_date":"2022-09-02","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BDTX"]}